Inside the Vancouver lab where scientists (legally) grow magic mushrooms
The Filament Health facility looks like something out of The Last of Us
Source: macleans.ca
Page 8 - Special Access News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Special Access. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Special Access Today - Breaking & Trending Today
For Canadian Patients, Therapeutic Psychedelics Beset by Red Tape
Critics say a program opening up patient access to psilocybin is a bureaucratic mess. Others say caution is appropriate.
Source: undark.org
Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ --Creso Pharma Limited(ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for the Australian market following recent regulatory changes. The Therapeutic Goods Administration (TGA), the medicine and therape...
Source: singaporestar.com
Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision
/PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life...
Source: prnewswire.com
Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ -- Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for...
Source: asiaone.com